Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10
Closed -$715 524
2023
Q4
$715 Hold
10
﹤0.01% 878
2023
Q3
$694 Hold
10
﹤0.01% 885
2023
Q2
$810 Sell
10
-29
-74% -$2.37K ﹤0.01% 903
2023
Q1
$3.15K Sell
39
-900
-96% -$72.5K ﹤0.01% 750
2022
Q4
$70.2K Buy
939
+900
+2,308% +$64.1K 0.01% 257
2022
Q3
$3K Hold
39
﹤0.01% 704
2022
Q2
$3K Sell
39
-135
-78% -$10K ﹤0.01% 692
2022
Q1
$13K Buy
+174
New +$12.5K ﹤0.01% 513

Other funds holding HOLX

Focused Wealth Management's HOLX Position: Q1 2024 in Review

Focused Wealth Management sold out of Hologic (HOLX) in Q1 2024, closing a stake of 10 shares — an estimated $715 sold.

Focused Wealth Management first reported a position in HOLX in Q1 2022 and held it in 8 quarters. The position peaked at $70.2K in Q4 2022. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2024.

  • Focused Wealth Management reported no remaining Hologic position as of Q1 2024 after selling out during the quarter.
  • Focused Wealth Management sold 10 Hologic shares in Q1 2024, an estimated $715.
  • Focused Wealth Management first reported a position in Hologic in Q1 2022 and held it in 8 quarters.
  • Focused Wealth Management's Hologic position peaked at $70.2K in Q4 2022.
  • 706 funds tracked by Wall St. Rank held Hologic as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.